Search

everythinglearnresearchcommunity

for

Search:↓

SHBG may be a useful early indicator and treatment target for PCOS.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

Low-dose oral contraceptives reduced hair growth and testosterone levels in women with polycystic ovary syndrome.

Both genetic and hormonal factors are crucial for bird sex differentiation, and disturbances can cause sex reversal.

Finasteride for hair loss may cause persistent sexual symptoms, depression, anxiety, and lower quality of life.

Women may need different blood pressure guidelines than men for heart disease prevention.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

Men with isolated hypogonadotropic hypogonadism have partial steroid deficiencies, while those with panhypopituitarism have severe deficiencies.

Human skin produces sex hormones like estrogen and testosterone, influenced by ARO and StAR, which may affect skin elasticity and hair growth.

Higher DHEAS levels may cause hair loss in women by disrupting hair growth.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Young women with diffuse hair loss may have low SHBG levels, which could lead to more active testosterone and contribute to their hair loss.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

Prenatal antiandrogen treatment altered hormone levels in adult spotted hyenas, affecting males and females differently.

People with hair loss have higher risk of high blood sugar and diabetes, and lower levels of a specific hormone.

Men and women have different levels and production of brain steroids, which may affect their risk for certain brain disorders.

SRD5A2 gene variations affect PTSD symptoms differently in males and females.

Sex hormone treatments can increase muscle mass in older adults but have inconsistent effects on muscle function and may carry cardiovascular risks.

Sex hormones affect brain injury differently in males and females.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

Male cancer patients have a higher risk of severe illness and death from COVID-19 than female patients.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Skin problems can be linked to sexual abuse, requiring careful medical and psychological evaluation.

Cross-sex hormone treatment in transsexual individuals helps understand how sex hormones affect diseases like heart disease and diabetes.

SHBG binding properties are unchanged in male liver cirrhosis patients.

Men with hair loss have lower SHBG and higher saliva testosterone levels, suggesting increased androgen activity.

Testosterone and its byproducts help support male sexual behavior through different pathways in the brain and body.

The document concludes that there is a significant lack of reporting on the sex and age of cells in skin research, which could affect clinical trials and treatments.

Male cells need DHT to respond to testosterone, while female cells do not.